Programs & Services
Specialties & Conditions
Research Areas
- Interstitial Lung Disease (ILD)
- Patient-reported outcome measures
- Quality of Life
Special Interests
Clinical Interests
My clinical interest is in evaluating and caring for patients with interstitial lung disease (ILD) of any cause. Aryeh Fischer, MD (Division of Rheumatology and Co-Director of the Autoimmune Lung Center) and I co-run a clinical research lab whose goal is to explore interesting and important clinical questions regarding ILD, including ILD related to connective tissue disease. The global focus of my individual research program is on how patients live with and experience ILD, how we assess that experience, and how we, as caretakers, might improve quality of life in patients suffering from ILD. I have a particular interest in developing and investigating so-called patient-reported outcomes (PRO) in ILD. These are instruments designed to capture patients' perceptions of what life is like with ILD and are used to assess whether and how therapeutic interventions affect patients.
Education
Education
|
Stanford University, MS (Epi) |
|
Ohio University College of Osteopathic Medicine, DO |
Residency
|
Cleveland Clinic Foundation, Internal Medicine |
|
Ohio University/Grandview Hospital, |
Fellowship
|
Stanford University, Research Fellow |
|
Stanford University, Pulmonary and Critical Care |
Awards & Recognition
2014: Best Doctors in America, Best Doctors, Inc.
2008: Nomination, Clinician of the Year, National Jewish Health
2005: Faculty Teaching Award, Division of Pulmonary and Critical Care Medicine, Stanford Scool of Medicine
2000: Senior Medical Resident of the Year, Cleveland Clinic Foundation
1997: Internal Medicine Fast Track Intern of the Year, Grandview Hospital
Board Certification
Pulmonary Diseases
Critical Care Medicine
Professional Memberships
American College of Chest Physicians
American Thoracic Society
Publications
Swigris JJ, Wamboldt FS, Behr J, du Bois R, King, Jr. TE, Raghu G, Brown KK. The six-minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference. Thorax 2010;65:173-177 PMID: 19996335
Swigris JJ, Brown KK, Behr J, du Bois R, King, Jr. TE, Raghu G, Wamboldt FS. The SF-36 and SGRQ: validity and first look at minimum important differences in IPF. Respir Med 2010;104:296-304 PMID: 19815403
Raghu G, King, Jr. TE, Behr J, Brown KK, du Bois RM, Leconte I, Roux S, Swigris JJ. Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1). Eur Respir J 2010;35:118-123 PMID: 19679600
Yorke J, Jones PW, Swigris JJ. Development and Validity Testing of an IPF-Specific Verstion of the SGRQ. Thorax 2010;65:921-926 PMID: 20861296
Swigris JJ, Wilson SR, Green KE, Brown KK, Wamboldt FS. Development of the ATAQ-IPF: a tool to assess quality of life in IPF. Health Qual Life Outcomes 2010;8:77 PMID: 20673370
Academic Affiliations
Associate Professor of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver
Teaching & Professional Positions
2011-Present: Associate Professor, National Jewish Health
2011-Present: Associate Professor of Medicine, University of Colorado
2003-2005: Clinical Instructor, Division of Pulmonary and Critical Care Medicine, Stanford University
Conflicts of Interest
National Jewish Health physicians and scientists may collaborate with pharmaceutical or other industries to develop medical and scientific breakthroughs or to provide education on trends in quality medical practice
and outcomes to physicians and health professionals around the country. National Jewish Health maintains a strict conflict of interest policy to ensure that all potential conflicts are clearly visible and that management
plans are put in place in order to further innovation and education while ensuring the protection of our patients and the integrity of our research. National Jewish Health publicly discloses any payment to our physicians
or scientists. View this faculty member’s industry relationships and collaborations.
Patient Ratings
The Patient Rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5, with 5 being the best score.
Learn more about our patient satisfaction survey.
Confidence in your doctor
5
Amount of time spent with you
4.9
Spoke using clear language
4.9
Includes you in decisions
5
Shows concerns for your questions
5
Explanation of problem/condition
4.9